Similar articles

• Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.

  Armstrong J, Toscano M, Kotchko N, Friedman S, Schwartz MD, Virgo KS, Lynch K, Andrews JE, Aguado Loi CX, Bauer JE, Casares C, Bourquardez Clark E, Kondoff MR, Molina AD, Abdollahian M, Walker G, Sutphen R. Armstrong J, et al. JAMA Oncol. 2015 Dec;1(9):1251-60. doi: 10.1001/jamaoncol.2015.3048. JAMA Oncol. 2015. PMID: 26426480
• Breast and ovarian cancer genetics and prevention.

  Altaha R, Reed E, Abraham J. Altaha R, et al. W V Med J. 2003 Sep-Oct;99(5):187-91. W V Med J. 2003. PMID: 14959510
• Oophorectomy in carriers of BRCA mutations.

  Peshkin BN, DeMarco TA, Schwartz MD. Peshkin BN, et al. N Engl J Med. 2002 Sep 26;347(13):1037-40; author reply 1037-40. N Engl J Med. 2002. PMID: 12353511 No abstract available.
• Evidence-based management options for women at increased breast/ovarian cancer risk.

  Pichert G, Bolliger B, Buser K, Pagani O; Swiss Institute for Applied Cancer Research Network for Cancer Predisposition Testing and Counseling. Pichert G, et al. Ann Oncol. 2003 Jan;14(1):9-19. doi: 10.1093/annonc/mdg030. Ann Oncol. 2003. PMID: 12488287 Review.
• Prevention and management of hereditary breast cancer.

  Narod SA, Offit K. Narod SA, et al. J Clin Oncol. 2005 Mar 10;23(8):1656-63. doi: 10.1200/JCO.2005.10.035. J Clin Oncol. 2005. PMID: 15755973 Review. No abstract available.